Usana Health Sciences (USNA) closed at $12.85 on November 11, 2026, down 1.9% from the previous close, on volume of 178,661 shares (30-day average 190,095).
Data as of November 11, 2026.
| # | Date | Strategy | Legs | Contracts |
|---|---|---|---|---|
| 1 | Nov 4, 2026 | Ratio Put Spread 3 by 7 | 16-Apr-275[7x] : 7.5[3x] P | 2,670 |
| 2-3 | The next 2 largest trades are for Premium members. Start a 7-day free trial | |||
Ranked by contracts: multi-leg trades of 200 or more contracts on one day, through Nov 11, 2026. See the 10 largest for 30, 60 and 90 days
USANA Health Sciences Earnings Call Signals Mixed Progress
TipRanks (Mon, 9-Nov 7:30 PM ET)
USANA Health Sciences Reports Third Quarter 2026 Results
Business Wire (Tue, 3-Nov 4:05 PM ET)
USANA BiOmega Earns ConsumerLab Seal of Approval for Quality and Purity
PRNewswire (Tue, 3-Nov 7:06 AM ET)
As Thanksgiving Nears, USANA CEO Kevin Guest Urges All to Rethink What Success Really Means
PRNewswire (Mon, 2-Nov 7:04 AM ET)
USANA Schedules Third Quarter 2026 Earnings Release and Conference Call
Business Wire (Mon, 12-Oct 4:30 PM ET)
USANA Health Sciences and University of Utah Athletics Announce New Partnership
PRNewswire (Wed, 7-Oct 7:07 AM ET)
USANA CEO Kevin Guest Shares Three Ways to Celebrate International Music Day
PRNewswire (Thu, 1-Oct 7:07 AM ET)
PRNewswire (Thu, 3-Sep 7:08 AM ET)
USANA CEO Kevin Guest Calls on People to Find a Way to Serve Others, Then Act
PRNewswire (Tue, 1-Sep 7:06 AM ET)
USANA Introduces 3-in-1 Protein, Creatine, and Electrolyte Drink Mix
PRNewswire (Mon, 17-Aug 7:13 AM ET)
Usana Health Sciences Inc develops and manufactures high-quality nutritional supplements, functional foods, and personal care products that are sold throughout the world. The company has developed and manufactured high-quality, science-based nutritional, personal care, and skincare products with a primary focus on promoting long-term health and wellness. The Company's reporting units for goodwill purposes are tied to its reportable segments: Core nutritional and Hiya direct-to-consumer. The core nutritional segment consists of three individual reporting units that are determined based on the operational nature of the business: Buy-Sell, China, and India. Geographically, it is in Asia Pacific, the Americas, and Europe. With the majority of revenue from Asia Pacific(Greater China).
Usana Health Sciences trades on the NYSE stock market under the symbol USNA.
As of November 12, 2026, USNA stock price declined to $12.78 with 62,857 million shares trading.
USNA has a beta of 0.09, meaning it tends to be less sensitive to market movements. USNA has a correlation of 0.00 to the broad based SPY ETF.
USNA has a market cap of $236.13 million. This is considered a Small Cap stock.
Last quarter Usana Health Sciences reported $206 million in Revenue and -$.11 earnings per share. This fell short of revenue expectation by $-12 million and missed earnings estimates by -$.22.
In the last 3 years, USNA traded as high as $54.81 and as low as $12.57.
The top ETF exchange traded funds that USNA belongs to (by Net Assets): VTI, IWM, DFSV, AVUV, VDC.
USNA has underperformed the market in the last year with a price return of -32.8% while the SPY ETF gained +12.5%. USNA has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -7.1% and -12.6%, respectively, while the SPY returned -1.0% and -1.5%, respectively.
USNA support price is $12.41 and resistance is $13.29 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that USNA shares will trade within this expected range on the day.
